JPRN-UMIN000011945已完成1 期
Phase 1/2 clinical trial of a sustained- release lidocaine sheet for postoperative pain - Phase 1/2 clinical trial of a sustained- release lidocaine sheet for postoperative pain
Department Of Anesthesiology Gunma University graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2014年1月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 50years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)A person taking a drug (e.g. antipsychotic, NSAIDs, and opioid) considered to participate in pain relief or judged that the influence is left even if canceled 2)A patient whose surgical site infects remarkably 3)A patient who has an allergy to Lidocaine, an amide type local anaesthetic agent, Celecoxib, a sulfonamide, Acetaminophen 4)A patient with a serious disturbance of conduction system (e.g. complete atrioventricular block) 5)A patient with peptic ulcer or asthma 6)A patient who has disturbance of consciousness or not able to communicate enough to evaluate correctly 7)A patient who is judged unsuitable for this trial by attending doctor
研究者
相似试验
已完成
2 期
A phase IIb randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients BLING IISevere Sepsis in the Intensive Care patientInfection - Studies of infection and infectious agentsBlood - Other blood disordersACTRN12612000138886HMRC442
已完成
不适用
Continuous administration trial of Phase2 Study of OCV-101 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancernresectable Advanced and Recurrent Pancreatic cancerJPRN-UMIN000009085OncoTherapy Science, Inc.2
已完成
不适用
Continuous administration trial of Phase2 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Biliary Tract Cancer and recurrent Biliary Tract Cancernresectable Advanced and Recurrent Biliary Tract CancerJPRN-UMIN000006436OncoTherapy Science, Inc.7
已完成
2 期
Phase II clinical trial of the first-line Stop-and-Go modified FOLFOX6 and bevacizmab for patients with unresectable/recurrent colorectal cancercolorectal cancerJPRN-UMIN000001233Mlnlstry of health, Labour and Welfare50
尚未招募
2 期
To determine whether the intensification of treatment in the form of chemotherapy and EGFR TKI gefitinib) combination increases survival among a â??high riskâ?? sub population of patients with lung cancer who have an EGFR mutatioCTRI/2022/02/040621CMC Vellore